Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma

BACKGROUND: The Response Evaluation Criteria in Solid Tumors (RECIST) for computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However, it does not reflect the pathological treatment response (PTR) of pancreatic ductal adenocarcinoma (PDAC). The Positron Emission Tomograp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Yokose, Takahiro, Kitago, Minoru, Matsusaka, Yohji, Masugi, Yohei, Shinoda, Masahiro, Yagi, Hiroshi, Abe, Yuta, Oshima, Go, Hori, Shutaro, Endo, Yutaka, Toyama, Kenji, Iwabuchi, Yu, Takemura, Ryo, Ishii, Ryota, Nakahara, Tadaki, Okuda, Shigeo, Jinzaki, Masahiro, Kitagawa, Yuko
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Clinical Cancer Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300404/
https://ncbi.nlm.nih.gov/pubmed/32281301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3044
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge